GS Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.77M Buy
3,015
+13
+0.4% +$13.2K 1.59% 25
2025
Q4
$3.23M Sell
3,002
-60
-2% -$57.4K 1.75% 25
2025
Q3
$2.34M Buy
3,062
+41
+1% +$30.5K 1.16% 34
2025
Q2
$2.35M Buy
3,021
+144
+5% +$112K 1.04% 37
2025
Q1
$2.38M Buy
+2,877
New +$2.39M 1.12% 34

Other funds holding LLY

GS Investments's LLY Position: Q1 2026 in Review

GS Investments increased its Eli Lilly (LLY) stake by 0.43% in Q1 2026, buying an estimated $13.2K and bringing the position to 3,015 shares worth $2.77M. The position accounts for 1.59% of the portfolio, ranked #25.

GS Investments first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.23M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • GS Investments held 3,015 shares of Eli Lilly worth $2.77M as of Q1 2026.
  • GS Investments bought 13 Eli Lilly shares in Q1 2026, an estimated $13.2K.
  • Eli Lilly made up 1.59% of GS Investments's portfolio in Q1 2026, its #25 holding.
  • GS Investments first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • GS Investments's Eli Lilly position peaked at $3.23M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on GS Investments's 13F filing for Q1 2026, filed 6 May 2026.